Email
16 Dec 2011

Novartis discontinues Estraderm patches

Product Novartis has announced it will be discontinuing its estrogen patches Estraderm TTS 25 and 100 as of January 1.
Forgotten your password?
The page you are looking for is only available to logged in members of Chemist+Druggist.
Not a member yet?
Register now
If you are not a registered user, then please sign up here. Registering is free and takes just seconds. It gives you access to up-to-the minute news alerts and analysis, all our top bloggers.
If you experience any difficulties logging in or registering, or have any other questions, please contact Chemist+Druggist at haveyoursay@chemistanddruggist.co.uk
Comment on this article
You are not currently logged in. Login or register
Your Comments
Linda Boucher, Non healthcare professional
Posted on 25 April 2012.
I have used the Estraderm patch since January 1993-first the lower dose and then the higher dose. I really felt this helps me with the symptoms of menopause. I wish it was not discontinued. I have tried 2 other patches and they make me bloat up and my breasts are very tender. I do not like them at all. BRING BACK THE ESTRADERM.
Sign in to vote.
Top

Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments.



 

Job of the week

Pharmacist & Technicians

Various locations

£45k + performance bonus

Follow C+D Jobs on